Spravato® (Esketamine) Treatment
Home » Spravato® (Esketamine) Treatment
Spravato® Evaluation and Treatment in Grand Prairie, Texas
Urgent Psych Rx – Evaluation-based care for adults with treatment-resistant depression
Urgent Psych Rx provides psychiatric evaluations for adults with ongoing depression symptoms, including patients whose symptoms have not improved enough with prior treatment. For eligible patients, Spravato® may be considered as part of a supervised treatment plan in a certified healthcare setting.
Spravato® treatment at Urgent Psych Rx is currently available in person at the Grand Prairie, Texas location only.
At Urgent Psych Rx Grand Prairie, Texas Location, we offer Spravato® (Esketamine) treatment, an FDA-approved breakthrough therapy designed specifically for individuals who have not
responded to conventional antidepressant medications.
Spravato works differently than traditional antidepressants and may help patients experience faster and more significant symptom improvement, even when other treatments have failed.
What Is Spravato®?
Spravato® is a prescription nasal spray medication containing esketamine. It is used for certain adults with treatment-resistant depression and must be administered under clinical supervision in a certified healthcare setting.
At Urgent Psych Rx, Spravato is not a take-home medication. Patients receive treatment in person at the Grand Prairie location and are monitored during and after each session. Eligibility and treatment recommendations are determined by a licensed provider after evaluation.
Who May Be Considered for a Spravato Evaluation?
A Spravato evaluation may be appropriate for adults who have ongoing depression symptoms despite prior treatment. During the evaluation, a provider reviews symptoms, diagnosis, medication history, medical history, safety considerations, and treatment goals.
Possible considerations may include:
• Ongoing depression symptoms despite previous treatment
• Prior antidepressant medication history
• Current medications and medical conditions
• Safety factors and monitoring needs
• Insurance or prior authorization requirements
• Whether Spravato is clinically appropriate
A psychiatric evaluation is required before any treatment recommendation is made. Not every patient will be eligible for Spravato.
Why Choose Urgent Psych Rx for Spravato Evaluation?
Every patient begins with a psychiatric evaluation to determine whether Spravato or another treatment option may be clinically appropriate.
Grand Prairie in-person treatment location
Spravato treatment is currently available in person at our Grand Prairie, Texas location only.
Supervised treatment setting
Spravato is administered in a monitored clinical setting. Patients are observed during and after treatment.
Medication management and treatment planning
Spravato, when appropriate, is considered as part of a broader care plan that may include medication management, therapy coordination, and ongoing follow-up.
Insurance support
Our team can help review benefits and prior authorization requirements when applicable. Coverage is not guaranteed and depends on the patient’s plan and medical criteria.
What to Expect
1. Psychiatric Evaluation
A licensed provider reviews your symptoms, treatment history, medical history, current medications, and care goals.
2. Eligibility and Treatment Planning
Your provider determines whether Spravato may be clinically appropriate or whether another treatment approach may be recommended.
3. Insurance Review, If Applicable
Our team may help review insurance benefits and prior authorization requirements. Insurance coverage is not guaranteed.
4. In-Person Treatment at Grand Prairie
If Spravato is recommended and approved, treatment takes place in person at the Grand Prairie, Texas location only.
5. Monitoring After Each Session
Patients are monitored during and after treatment. Patients must arrange transportation home and should not drive the same day after treatment.
Spravato Treatment Schedule
Spravato treatment typically occurs in two phases:
Induction Phase:
Twice weekly treatments for the first 4 weeks
Maintenance Phase:
Weekly or biweekly sessions depending on patient response.
Insurance Coverage
Many commercial insurance plans cover Spravato treatment when medical criteria are met.
Our clinic works with major insurance providers including:
• Blue Cross Blue Shield
• Aetna
• UnitedHealthcare
• Cigna
• Humana
• Optum
• Anthem
• Employer-sponsored PPO plans
Start With a Spravato Evaluation
If depression symptoms have not improved enough with prior treatment, a psychiatric evaluation can help clarify next-step care options. For eligible patients, Spravato may be considered as part of a supervised treatment plan.
Spravato treatment is currently available in person at the Grand Prairie, Texas location only. Evaluation is required, and individual results vary.
Our staff will assist with:
• Insurance verification
• Prior authorization
• Manufacturer savings programs
Schedule Your Spravato Consultation
Contact Urgent Psych Rx today to learn if Spravato treatment is right for you.
Call our office or request an appointment online to begin your evaluation.
Relief from treatment-resistant depression may be closer than you think.
Spravato Treatment FAQ
SPRAVATO® Patient Stories and Expert Perspectives
Watch real patients and healthcare experts discuss treatment-resistant depression and SPRAVATO®. These non-animated videos are provided by the official SPRAVATO HCP video library.
SPRAVATO® is a prescription medicine administered only in a certified healthcare setting. Individual experiences vary. View the official SPRAVATO® video library.
Secure next steps
Request a Spravato® Evaluation
Begin through the clinic’s secure scheduling system. Spravato treatment is available in person at our Grand Prairie, Texas location only. Scheduling does not confirm eligibility; a psychiatric evaluation and clinical review are required.
Frequently Asked Questions About Spravato® Treatment in Texas
Spravato® is an FDA-approved prescription nasal spray containing esketamine, a medication used to treat treatment-resistant depression (TRD) and major depressive disorder with suicidal thoughts or behaviors.
Unlike traditional antidepressants that primarily affect serotonin, Spravato works on the brain’s glutamate system, helping restore neural connections that are often impaired in depression.
Spravato is administered only in a certified medical facility under clinical supervision, such as the Spravato Treatment Center at Urgent Psych Rx.
Treatment-resistant depression occurs when a patient has tried two or more antidepressant medications without adequate improvement.
Many individuals with treatment-resistant depression continue to struggle with symptoms including:
• persistent sadness
• low motivation
• fatigue
• sleep disturbances
• difficulty concentrating
• loss of interest in activities
Spravato was specifically developed for patients who have not experienced relief with standard antidepressant medications.
Spravato works differently than traditional antidepressants.
Instead of targeting serotonin alone, Spravato affects NMDA receptors and glutamate signaling in the brain, which may help restore healthy communication between brain cells.
This mechanism may allow some patients to experience faster improvement in depressive symptoms compared to conventional antidepressants.
Response to Spravato varies by patient. Some patients may notice changes earlier, while others may experience gradual changes over time or may not respond. Your provider will monitor progress and discuss ongoing treatment recommendations based on your individual response.
Individual responses vary depending on:
• severity of depression
• treatment history
• other medications
• overall mental health condition
Your provider will monitor progress throughout treatment.
Spravato is delivered as a nasal spray during supervised treatment sessions.
Each appointment includes:
1. Administration of the medication
2. Monitoring for safety
3. Observation period lasting approximately two hours
Patients must arrange transportation home after treatment because driving is not allowed the same day.
Spravato treatment typically occurs in two phases.
- Induction Phase: Twice weekly sessions for the first 4 weeks
2. Maintenance Phase: Weekly or every two weeks depending on response.
Your provider will personalize the treatment plan based on clinical progress.
Spravato has been studied in multiple clinical trials and approved by the FDA for specific forms of depression.
Common temporary side effects may include:
• dizziness
• dissociation
• nausea
• mild sedation
• increased blood pressure
Patients are monitored during treatment to ensure safety and comfort.
Some insurance plans may cover Spravato when medical criteria and prior authorization requirements are met. Coverage, patient responsibility, and approval are not guaranteed. Our team can help review benefits when applicable.
The best way to determine eligibility is through a psychiatric evaluation with a qualified provider.
The only way to determine whether Spravato may be clinically appropriate is through a psychiatric evaluation with a licensed provider. The provider will review your diagnosis, medication history, current symptoms, medical history, safety considerations, and treatment goals. Not every patient is eligible for Spravato.
Spravato Evaluation and Treatment in Grand Prairie, Texas
Advanced Treatment for Treatment-Resistant Depression
Urgent Psych Rx provides evaluation-based care for adults with treatment-resistant depression. For eligible patients, Spravato may be considered as part of a supervised treatment plan. Treatment is administered in person at our Grand Prairie, Texas location only and includes monitoring during and after each session.
Our broader depression care approach may include psychiatric evaluation, medication management, treatment planning, therapy coordination, and ongoing follow-up.
Evaluation is required before treatment recommendations are made. Individual results vary.
Why Patients in Texas Choose Spravato
Many individuals turn to Spravato because it offers several unique advantages:
• FDA-approved treatment specifically for treatment-resistant depression
• different mechanism than traditional antidepressants
• potential for faster symptom improvement
• administered under medical supervision for safety
For many patients, Spravato represents a new opportunity for symptom relief when other
treatments have failed.
Comprehensive Depression Care
At Urgent Psych Rx, Spravato treatment is part of a broader mental health care approach that includes:
• psychiatric evaluation
• medication management
• individualized treatment planning
• ongoing symptom monitoring
This integrated approach helps ensure patients receive the most effective and appropriate care for their condition.
Insurance Coverage for Spravato in Texas
Spravato treatment may be covered by many commercial insurance providers when medical criteria are met.
Our staff assists with:
• insurance verification
• prior authorization
• coordination with insurance providers
This process helps make treatment more accessible and affordable for eligible patients.
Schedule a Spravato Consultation in Texas
If depression has not improved with traditional medications, it may be time to explore advanced treatment options.
The Spravato Treatment Center at Urgent Psych Rx provides compassionate, evidence-based care for individuals seeking relief from treatment-resistant depression.
Contact our office today to schedule a consultation and learn whether Spravato treatment may be right for you.